Ledger.Open graph →
SEC Form D · filed May 11, 2021

ONCOQUEST PHARMA USA, INC

Offering
$360K
Sold
$360K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MIRYANG SI, GYEONGSANGNAMDO, M5
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Ragupathy Madiyalakan · Edmonton, Alberta, CanadaExec · DirectorSudheesh N. Vadakkedath · San Jose, CAExec · DirectorAlex Jung · MIRYANG SI, GYEONGSANGNAMDO, M5Exec · DirectorLyn Lim · MIRYANG SI, GYEONGSANGNAMDO, M5DirectorKarthik Radhakrishnan · The Woodlands, TXExec · DirectorXing X. Zheng · Great Neck, NYExec · DirectorAlex Jung · MIRYANG SI, GYEONGSANGNAMDO, M5Exec · DirectorLyn Lim · MIRYANG SI, GYEONGSANGNAMDO, M5DirectorKarthik Radhakrishnan · The Woodlands, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗